Skip to content

Sotera Health SHC Free cash flow

Free cash flow at other companies

Natera, Inc. logo
Natera, Inc.NTRA
$18.03M-20.3%
Charles River Laboratories logo
Charles River LaboratoriesCRL
STERIS logo
STERISSTE
Fortive logo
FortiveFTV
Oklo logo
OkloOKLO
Labcorp Holdings logo
Labcorp HoldingsLH

Other financials

Income statement

See full
Revenue$280.0M+10.0%
Gross profit$147.1M+8.6%
Operating income$87.1M-16.2%
Net income$26.6M+301%
EPS (diluted)$0.09+280%

Balance sheet

See full
Cash & equivalents$314.1M+3.2%
Total debt$2.3B-3.2%
Total equity$622.5M+50.3%
Total assets$3.2B+4.5%

Cash flow

See full
Operating cash flow$29.4M-47.0%
CapEx$46.2M+132%

Valuation

See full
Market cap$4.51B+23.4%
Enterprise value$6.47B+12.8%
P/E38.3×-109×
P/S3.8×+0.5×

Profitability

See full
Gross margin55.3%+0.1pp
Operating margin27%+0.7pp
Net margin9.9%+7.7pp
FCF margin8.1%

Returns & leverage

See full
Return on equity22.7%+16.8pp
Debt / equity3.6×-2.0×
Current ratio2.8×+0.4×

Where this comes from

Calculated from Sotera Health’s reported figures.

The official record: Sotera Health’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sotera Health's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sotera Health's free cash flow?
Sotera Health (SHC) reported free cash flow of -$16.73M in Q1 2026.
How has Sotera Health's free cash flow changed year-over-year?
Sotera Health's free cash flow decreased by 147.0% year-over-year, from $35.6M to -$16.73M.
What is the long-term trend for Sotera Health's free cash flow?
Over 2 years (2021 to 2025), Sotera Health's free cash flow has grown at a -8.8% compound annual growth rate (CAGR), from $179.38M to $149.18M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.